Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Market Value Added (MVA)

Microsoft Excel

MVA

Pfizer Inc., MVA calculation

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Fair value of debt1 60,946 71,350 32,945 44,241 48,236
Operating lease liability 2,642 3,153 3,217 2,959 1,435
Market value of common equity 147,918 155,569 237,687 258,449 188,635
Equity attributable to noncontrolling interests 294 274 255 261 235
Less: Marketable securities 20,725 12,813 25,552 33,556 13,411
Market (fair) value of Pfizer 191,075 217,533 248,552 272,354 225,130
Less: Invested capital2 135,777 154,882 110,746 87,670 103,898
MVA 55,298 62,651 137,806 184,684 121,232

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Fair value of debt. See details »

2 Invested capital. See details »

Item Description The company
MVA Pfizer Inc. market (fair) value less invested capital. Pfizer Inc. MVA decreased from 2022 to 2023 and from 2023 to 2024.

MVA Spread Ratio

Pfizer Inc., MVA spread ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Market value added (MVA)1 55,298 62,651 137,806 184,684 121,232
Invested capital2 135,777 154,882 110,746 87,670 103,898
Performance Ratio
MVA spread ratio3 40.73% 40.45% 124.43% 210.66% 116.68%
Benchmarks
MVA Spread Ratio, Competitors4
AbbVie Inc. 483.23% 438.96% 297.39% 253.64% 172.70%
Amgen Inc. 238.60% 213.63% 308.27% 303.88% 343.98%
Bristol-Myers Squibb Co. 155.28% 100.64% 160.91% 138.81% 109.83%
Danaher Corp. 123.11% 157.62% 156.95% 187.44% 172.97%
Eli Lilly & Co. 2,281.36% 2,390.18% 1,239.79% 833.40% 778.02%
Gilead Sciences Inc. 276.96% 148.05% 175.26% 119.58% 125.56%
Johnson & Johnson 288.70% 309.06% 288.40% 366.82% 363.75%
Merck & Co. Inc. 231.53% 412.35% 312.72% 223.02% 292.93%
Regeneron Pharmaceuticals Inc. 416.61% 663.41% 521.52% 461.61% 508.24%
Thermo Fisher Scientific Inc. 182.22% 189.54% 195.34% 212.01% 232.34%
Vertex Pharmaceuticals Inc. 1,158.91% 712.26% 484.09% 564.91% 575.24%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 MVA. See details »

2 Invested capital. See details »

3 2024 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × 55,298 ÷ 135,777 = 40.73%

4 Click competitor name to see calculations.

Performance ratio Description The company
MVA spread ratio The ratio of MVA to invested capital. It measures the efficiency with which investors’ capital investment has translated into a franchise value and into an aggregate net present value premium. Pfizer Inc. MVA spread ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024.

MVA Margin

Pfizer Inc., MVA margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Market value added (MVA)1 55,298 62,651 137,806 184,684 121,232
Revenues 63,627 59,553 101,175 82,145 42,678
Performance Ratio
MVA margin2 86.91% 105.20% 136.21% 224.83% 284.06%
Benchmarks
MVA Margin, Competitors3
AbbVie Inc. 594.14% 551.18% 420.74% 432.93% 391.08%
Amgen Inc. 470.63% 555.51% 493.74% 503.37% 550.26%
Bristol-Myers Squibb Co. 201.43% 151.08% 250.01% 240.26% 232.86%
Danaher Corp. 380.02% 517.54% 389.99% 468.46% 507.10%
Eli Lilly & Co. 1,813.26% 2,058.21% 1,055.66% 769.29% 778.57%
Gilead Sciences Inc. 429.17% 251.89% 295.97% 211.56% 259.24%
Johnson & Johnson 346.20% 359.73% 345.74% 383.60% 433.17%
Merck & Co. Inc. 286.58% 479.92% 390.05% 323.90% 349.01%
Regeneron Pharmaceuticals Inc. 365.32% 605.08% 525.04% 312.14% 495.20%
Thermo Fisher Scientific Inc. 348.77% 378.46% 360.17% 431.35% 441.03%
Vertex Pharmaceuticals Inc. 951.31% 955.82% 714.32% 700.10% 754.94%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 MVA. See details »

2 2024 Calculation
MVA margin = 100 × MVA ÷ Revenues
= 100 × 55,298 ÷ 63,627 = 86.91%

3 Click competitor name to see calculations.

Performance ratio Description The company
MVA margin The ratio of MVA to sales. It measures how efficiently and prodigiously sales translate into franchise value. Pfizer Inc. MVA margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024.